US1196419-100MG | 196419-100MG | BAPTA/AM |
US1196419-25MG | 196419-25MG | BAPTA/AM |
US1196440-5MG | 196440-5MG | Batimastat |
US1196805-5MG | 196805-5MG | BAX CHANNEL BLOCKER |
| 196806-10MG | Bax Channel Blocker II, iMAC2 |
US1196810-5MG | 196810-5MG | BAX-INHIBITING PEPTIDE, V5 |
US1196811-5MG | 196811-5MG | BAX-INHIBITING PEPTIDE, NEGATIVE CONTROL |
US1196821-100UL | 196821-100UL | ANTI-BAX (44-62) RABBIT PAB |
US1196870-10MG | 196870-10MG | BAY 11-7082 |
US1196871-10MG | 196871-10MG | INSOLUTION(TM) BAY 11-7082 |
US1196872-10MG | 196872-10MG | BAY 11-7085 |
US1196876-5MG | 196876-5MG | BAY 41-2272 |
US1196878-1MG | 196878-1MG | (+/-)-BAY K 8644 |
US1196878-5MG | 196878-5MG | (+/-)-BAY K 8644 |
US1197209-100UG | 197209-100UG | ANTI-BCL-W (16-29) RABBIT PAB |
US1197210-50NMOL | 197210-50NMOL | BCL-2 ANTISENSE OLIGONUCLEOTIDE, CONTROL |
US1197217-1MG | 197217-1MG | BCL-XL BH4(4-23) (HUMAN), CELL-PERMEABLE |
US1197220-1MG | 197220-1MG | BCL-2 BINDING PEPTIDE, CELL-PERMEABLE |
US1197221-5MG | 197221-5MG | BCR-ABL INHIBITOR |
US1197222-6000U | 197222-6000U | BCL-10, HIS-TAG, HUMAN, WILD TYPE, RECOM |
US1197223-5MG | 197223-5MG | BCR-ABL INHIBITOR II |
US1197225-1MG | 197225-1MG | BCL-2 BINDING PEPTIDE, NEG. CONTROL |
US1197320-2MG | 197320-2MG | BCL-2 CONVERTER,D-NUBCP-9-R8,CELL-PERMEA |
US1197330-5MG | 197330-5MG | BCL-2 INHIBITOR |
US1197331-5MG | 197331-5MG | BCL-2 INHIBITOR II, YC137 |
US1197332-10MG | 197332-10MG | BCL-2 INHIBITOR III |
US1197333-5MG | 197333-5MG | BCL-2 INHIBITOR VI, ABT-737 |
US1197900-5MG | 197900-5MG | BEC, HYDROCHLORIDE |